Crystal Pacific (00575): Deep Longevity expands its business in the US and appoints key executives by 2026

Zhitong Finance App News, Li Jing Pacific (00575) announced that Deep Longevity, Inc., a global leader in artificial intelligence-driven aging clocks and longevity science, and its subsidiaries (collectively, “Deep Longevity”) have appointed Dylan Kay as Chief Commercial Officer of the United States of America (US) and Luke Shaffer as Vice President of US Sales. Both will officially take office on January 1, 2026.

This appointment marks Deep Longevity's active entry into the US, the world's largest health market, and is scheduled to commence commercial operations in the first quarter of 2026.

Mr. Kay has over 15 years of experience with large-scale enterprise health technology and digital therapy platforms, and has recently driven nine digit growth in Livongo (now Teladoc Health) and OneDrop. Mr. Shaffer previously worked for a major corporate health service provider and was responsible for leading partnerships with Fortune 500 employers and health plans.

Together, they will lead sales and partnership development in four key areas:

•Corporate health and welfare plans

• Health insurance and risk bearing entities

• Diagnostic Laboratories and Longevity Clinics

•High-end consumer health platform

Deep Longevity's clinically proven aging clocks — including BloodAge, Epigeneticage, MindAge, Biometricage, and upcoming FaceAge — provide multi-modal, actionable insights into molecular, physiological, cognitive, and psychological aging. Deep Longevity's Software-as-a-Service (SaaS) © solutions enable employers and insurers to transition from passive disease care to providing quantifiable, personalized longevity plans proven to increase healthy longevity and reduce long-term costs.

Deepankar Nayak (CEO of Deep Longevity) said, “Currently, 90% of the US $4.5 trillion in medical expenses each year are due to chronic diseases. Dylan and Luke are proven, hands-on talents who have transformed emerging science into enterprise-level influence many times. Under their leadership, we are fully prepared to place the clock of deep aging at the center of America's preventive health revolution.”

Deep Longevity has set an ambitious goal and plans to sign more than 50 US corporate clients by the end of 2026.